ORIGINAL RESEARCH
Accepted on 30 Sep 2025
Cost-effectiveness analysis of cabozantinib plus atezolizumab for advanced hepatocellular carcinoma
doi 10.3389/fphar.2025.1556304
266
Total downloads
2,240
Total views and downloads
Submit your idea
You will be redirected to our submission process.
ORIGINAL RESEARCH
Accepted on 30 Sep 2025
REVIEW
Accepted on 29 Sep 2025
ORIGINAL RESEARCH
Published on 11 Sep 2025
ORIGINAL RESEARCH
Published on 14 Aug 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.